Inceptionr LLC Abb Vie Inc. Transaction History

Inceptionr LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $794,915 - $895,261	5,777 New	5,777 $895 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $221,954 - $276,207	-1,675 Reduced 16.84%	8,270 $1.11 Billion
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $1.44 Million - $1.66 Million	9,945 New	9,945 $1.58 Billion

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

Stay updated on Inceptionr LLC with notifications on news.